Alpha Teknova Q3 revenue up 14% to $10.7M, net loss widens on $16.6M goodwill impairment

Alpha Teknova, Inc.

2023-Q3 EPS reported -$1.22 revenue$33,529,000

Revenue $10.7M (+14% YoY); Lab Essentials $9.47M (+32%).
Net loss $22.5M ($0.80 loss per share) vs loss $3.3M in Q3 2021; includes $16.6M non-cash goodwill impairment.
Adjusted EBITDA -$4.6M vs -$2.7M; Free Cash Flow -$14.9M.
FY2022 revenue guidance lowered to $40-42M (midpoint ~16% growth excl. Sample Transport).
Cash $49.9M; new facility qualification underway, research-grade production expected by end of 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.